AUS
NZ
UK
CA
USA
IND
Highlights
-
Potential Split: CVS Health Corp is considering separating its retail and insurance divisions, potentially creating two publicly traded entities.
-
Investor Pressure: The move comes in response to investor concerns following a lowered 2024 profit forecast and calls for strategic changes from major stakeholders like Glenview Capital.
-
Stock Performance: CVS shares have declined nearly 25% this year, primarily due to rising costs in its Medicare business and operational challenges.
CVS Health Corp {NYSE:CVS} is reportedly exploring options to separate its retail and insurance divisions amid increasing pressure from investors, as revealed in an exclusive report by Reuters. This potential split could result in the formation of two publicly traded entities, effectively reversing CVS's significant $70 billion acquisition of Aetna.
The company is currently in discussions with financial advisers and its board regarding this strategic move, although no final decision has been made. In addition to the potential separation, CVS is also evaluating the future of its pharmacy benefits manager unit, which has been a point of contention among investors.
The exploration of these options follows CVS's recent decision to lower its profit forecast for 2024, prompting urgent calls for strategic reevaluation from influential investors. Notably, Glenview Capital has been vocal in advocating for change within the organization.
CVS's stock has faced considerable challenges this year, with shares plummeting nearly 25%. This decline has been attributed to escalating costs within its Medicare business, along with broader operational difficulties. As CVS navigates these challenges, the outcome of its strategic considerations may significantly impact its future direction and market positioning.
